VRCA- Verrica Pharmaceuticals Inc.

Name: Verrica Pharmaceuticals Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Verrica Pharmaceuticals Inc. (VRCA) has 9 insiders with recent SEC Form 4 filings, including 10 buys and 3 sells. VRCA is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Manning Paul B	3.35M	$27.02M	-
CEO	Rieger Jayson	182.6K	$1.47M	-
COO	Zawitz David	21.0K	$169.5K	-
Dir	Eichenfield Lawrence	20.0K	$161.4K	-
Dir	Prygocki Mark A Sr	20.0K	$161.4K	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Nov 25, 2025	Kirby John J.	Interim CFO	Buy	3,536	$4.24	$15,001.48	+65.2%	+9.4%	-
Nov 25, 2025	Zawitz David	Chief Operating Officer	Buy	10,000	$4.24	$42,425.00	+90.9%	+9.4%	-
Nov 25, 2025	Rieger Jayson	CEO And President	Buy	94,311	$4.24	$400,114.42	+106.8%	+9.4%	-
Nov 25, 2025	Rosenberg Noah L.	CMO	Buy	2,357	$4.24	$9,999.57	New	+9.4%	-
Nov 25, 2025	Manning Paul B53	Director, 10% Owner	Buy	4,126,142	$4.24	$17,505,157.44	+129.7%	+9.4%	-
Mar 17, 2025	Hayes Christopher G.70	Chief Legal Officer	Sell	4,315	$0.65	$2,804.75	-2.4%	+1.3%	-3.0%
Nov 22, 2024	Manning Paul B53	Director, 10% Owner	Buy	22,921,348	$0.00	-	+245.6%	-25.4%	-57.7%
Nov 22, 2024	Rieger Jayson	CEO And President	Buy	280,898	$0.00	-	+50.9%	-25.4%	-57.7%
Nov 22, 2024	Stalfort John A III	Director	Buy	1,123,595	$0.00	-	+160.5%	-25.4%	-57.7%
Aug 27, 2024	Hayes Christopher G.70	Chief Legal Officer	Sell	35,713	$2.61	$93,090.58	-13.9%	-59.7%	-77.0%

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC